Literature DB >> 12446063

Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea.

Damien Logeart1, Carole Saudubray, Pascale Beyne, Gabriel Thabut, Pierre-Vladimir Ennezat, Christophe Chavelas, Caroline Zanker, Erik Bouvier, Alain Cohen Solal.   

Abstract

OBJECTIVES: We compared the accuracy of B-type natriuretic peptide (BNP) assay with Doppler echocardiography for the diagnosis of decompensated congestive left-heart failure (CHF) in patients with acute dyspnea.
BACKGROUND: Both BNP and Doppler echocardiography have been described as relevant diagnostic tests for heart failure.
METHODS: One hundred sixty-three consecutive patients with severe dyspnea underwent BNP assay and Doppler echocardiogram on admission. The accuracy of the two methods for etiologic diagnosis was compared on the basis of the final diagnoses established by physicians who were blinded to the BNP and Doppler findings.
RESULTS: The final etiologic diagnosis was CHF in 115 patients. Twenty-four patients (15%) were misdiagnosed at admission. The BNP concentration was 1,022 +/- 742 pg/ml in the CHF subgroup and 187 +/- 158 pg/ml in the other patients (p < 0.01). A BNP cutoff of 300 pg/ml correctly classified 88% of the patients (odds ratio [OR] 85 [19 to 376], p < 0.0001), but a high negative predictive value (90%) was only obtained when the cutoff was lowered to 80 pg/ml. The etiologic value of BNP was low in patients with values between 80 and 300 pg/ml (OR 1.85 [0.4 to 7.8], p = 0.4) and also in patients who were studied very soon after onset of acute dyspnea. Among the 138 patients with assessable Doppler findings, a "restrictive" mitral inflow pattern had a diagnostic accuracy for CHF of 91% (OR 482 [77 to 3,011], p < 0.0001), regardless of the BNP level.
CONCLUSIONS: Bedside BNP measurement and Doppler echocardiography are both useful for establishing the cause of acute dyspnea. However, Doppler analysis of the mitral inflow pattern was more accurate, particularly in patients with intermediate BNP levels or "flash" pulmonary edema.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446063     DOI: 10.1016/s0735-1097(02)02482-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  26 in total

1.  B-type natriuretic peptides for prediction and diagnosis of weaning failure from cardiac origin.

Authors:  Lluís Zapata; Paula Vera; Antoni Roglan; Ignasi Gich; Jordi Ordonez-Llanos; Antoni J Betbesé
Journal:  Intensive Care Med       Date:  2010-12-09       Impact factor: 17.440

Review 2.  Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.

Authors:  Stephen A Hill; Ronald A Booth; P Lina Santaguida; Andrew Don-Wauchope; Judy A Brown; Mark Oremus; Usman Ali; Amy Bustamam; Nazmul Sohel; Robert McKelvie; Cynthia Balion; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

3.  Prognostic Value of Serial N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients With Acute Myocardial Infarction.

Authors:  Michael C Kontos; David E Lanfear; Kensey Gosch; Stacie L Daugherty; Paul Heidenriech; John A Spertus
Journal:  Am J Cardiol       Date:  2017-04-27       Impact factor: 2.778

4.  Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study.

Authors:  Hafid Ait-Oufella; Pierre-Louis Tharaux; Jean-Luc Baudel; Sophie Vandermeersch; Pascal Meyer; Marc Tonnellier; Jean-Claude Dussaule; Bertrand Guidet; Georges Offenstadt; Eric Maury
Journal:  Intensive Care Med       Date:  2007-04-03       Impact factor: 17.440

5.  Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea.

Authors:  Patrick Ray; Martine Arthaud; Yannick Lefort; Sophie Birolleau; Catherine Beigelman; Bruno Riou
Journal:  Intensive Care Med       Date:  2004-10-22       Impact factor: 17.440

6.  Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism.

Authors:  Damien Logeart; Lucien Lecuyer; Gabriel Thabut; Jean-Yves Tabet; Jean-Michel Tartière; Christophe Chavelas; François Bonnin; Jean-Louis Stievenart; Alain Cohen Solal
Journal:  Intensive Care Med       Date:  2006-12-13       Impact factor: 17.440

7.  [Essential cardiac biomarkers in myocardial infarction and heart failure].

Authors:  M Mueller; E Giannitsis; H A Katus
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

Review 8.  B-type natriuretic peptide measurement in heart failure.

Authors:  Daniel M Spevack; Arthur Schwartzbard
Journal:  Clin Cardiol       Date:  2004-09       Impact factor: 2.882

9.  Accuracy of chest radiographs in the emergency diagnosis of heart failure.

Authors:  Ueli Studler; Martin Kretzschmar; Michael Christ; Tobias Breidthardt; Markus Noveanu; Andreas Schoetzau; André P Perruchoud; Wolfgang Steinbrich; Christian Mueller
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

10.  Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide.

Authors:  Ken Shimamoto; Natsuha Koike; Kiyoko Mizuochi; Miho Honma; Yufuko Kasai; Akiko Sakai; Etsuko Fujita; Masatoshi Kawana
Journal:  BMC Cardiovasc Disord       Date:  2009-01-24       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.